Translating Early Stage Drug Discovery Research into a Commercially Viable Clinical Benefit
From the 2nd - 3rd December the NG 30 Drug Discovery Summit Europe will bring together 30 senior pharmaceutical executives and business leaders, specialising in drug discovery, from across the region.
The event aims to solve key business challenges within the drug discovery sector. In particular, the ability to network and learn from industry peers through essential business conversation.
Working in partnership with our network of senior executives we identify the key industry themes. These form the foundation of our summit and permeate every layer of the content-rich program.
These three core themes represent the business critical challenges driving your conversations at the summit.
Three Key Themes
Stem cell technology and new patient models
Content management systems and pre-competitive collaboration
Late Stage Attrition
Contract research, toxicology and high performance computing
Partnering Companies Include
In 2013, a truly excellent 1,083 of our customers generously gave some of their time to share feedback. This is what they told us.
96.1% of all attendees were satisfied or very satisfied with the summit
88% of attendees will be doing business with a solution provider they met at the summit
92% of all attendees would recommend our summit to their peers